Voloridge Investment Management’s Legend Biotech LEGN Stock Holding History

Voloridge Investment Management’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-14,595	Closed	-$878K	–	1260
2023 Q4	$878K	Sell	14,595 -127,843	-90%	-$8.1M	﹤0.01%	963
2023 Q3	$9.57M	Sell	142,438 -7,913	-5%	-$550K	0.05%	471
2023 Q2	$10.4M	Buy	+150,351	New	+$9.82M	0.05%	455
2022 Q3	–	Sell	-55,673	Closed	-$3.06M	–	1520
2022 Q2	$3.06M	Sell	55,673 -162,342	-74%	-$6.86M	0.02%	868
2022 Q1	$7.92M	Buy	218,015 +41,959	+24%	+$1.66M	0.04%	487
2021 Q4	$8.21M	Buy	176,056 +74,508	+73%	+$3.78M	0.04%	527
2021 Q3	$5.13M	Buy	101,548 +14,376	+16%	+$598K	0.03%	669
2021 Q2	$3.58M	Buy	87,172 +41,903	+93%	+$1.42M	0.02%	759
2021 Q1	$1.31M	Buy	+45,269	New	+$1.23M	0.01%	950

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Voloridge Investment Management's LEGN Position: Q1 2024 in Review

Voloridge Investment Management sold out of Legend Biotech (LEGN) in Q1 2024, closing a stake of 14,595 shares — an estimated $878K sold.

Voloridge Investment Management first reported a position in LEGN in Q1 2021 and held it in 9 quarters. The position peaked at $10.4M in Q2 2023. 192 funds tracked by Wall St. Rank hold LEGN as of Q1 2024.

Voloridge Investment Management reported no remaining Legend Biotech position as of Q1 2024 after selling out during the quarter.
Voloridge Investment Management sold 14,595 Legend Biotech shares in Q1 2024, an estimated $878K.
Voloridge Investment Management first reported a position in Legend Biotech in Q1 2021 and held it in 9 quarters.
Voloridge Investment Management's Legend Biotech position peaked at $10.4M in Q2 2023.
192 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2024.

Based on Voloridge Investment Management's 13F filing for Q1 2024, filed 15 May 2024.